Adductor Canal Block Versus Femoral Block on Pain and Quadriceps Strength
NCT ID: NCT05190120
Last Updated: 2025-09-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
132 participants
INTERVENTIONAL
2016-01-31
2022-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Adductor Canal Block for Total Knee Arthroplasty Analgesia
NCT02387021
Femoral Triangle Block: Early Mobilization and Postoperative Analgesia After Total Knee Arthroplasty
NCT03518450
Adductor Canal Block Versus Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction Arthroscopically
NCT02355093
Analgesic Efficacy of Anterior Femoral, Genicular and Adductor Canal Nerve Block
NCT02548104
Adductor Canal Block and Arthroscopic Knee Surgery, High Pain Responders
NCT02001662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will prospectively randomize patients undergoing knee arthroscopy at the UCSF Orthopaedic Institute to receive either a single-shot femoral nerve or adductor canal block pre-operatively after taking baseline measurements of quadriceps strength (quantified by maximum voluntary isometric contraction). The quadriceps muscle strength will be checked 20 minutes after the nerve block to assess strength. All patients will subsequently undergo a general anesthetic. The primary outcome variable will be post-block quadriceps strength as a percentage of baseline from pre-block values. Secondary outcome variables that will also investigated include: VAS pain score in the post anesthesia recovery unit and post-operative day 1, duration of nerve blockade, and perioperative opioid consumption.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Femoral Block
Patients scheduled for knee arthroscopy will have a femoral nerve block done using 0.5% ropivacaine 20ml before surgery.
Femoral Nerve Block
Patients having ACL reconstruction, meniscus surgery and knee arthroscopy
preoperative Femoral Nerve Block using 20ml of 0.5% ropivacaine
Adductor Canal Block
Patients scheduled for knee arthroscopy will have an adductor canal block done using 0.75% ropivacaine 13.3ml before surgery.
Adductor Canal Nerve Block
Patients having ACL reconstruction, meniscus surgery and knee arthroscopy
Preoperative Adductor canal block with 0.75%% ropivacaine 13.3ml.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Femoral Nerve Block
Patients having ACL reconstruction, meniscus surgery and knee arthroscopy
Adductor Canal Nerve Block
Patients having ACL reconstruction, meniscus surgery and knee arthroscopy
preoperative Femoral Nerve Block using 20ml of 0.5% ropivacaine
Preoperative Adductor canal block with 0.75%% ropivacaine 13.3ml.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for arthroscopic knee surgery (meniscal debridement/repair, ACL reconstruction)
Exclusion Criteria
* Non-English speaking
* Any contraindication for regional anesthesia, such as allergy to local anesthetics or opioids, -Coagulopaty or severe thrombocytopenia
* Infection at puncture sites
* Pre-existing neuropathy in operative limb
* Need for post-operative nerve function monitoring
* Dementia
* Patient refusal
* High pre-operative opioid requirements
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pedram Aleshi, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCSF Orthopedic Trauma Service
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-13071
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.